<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1738">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04480411</url>
  </required_header>
  <id_info>
    <org_study_id>56472</org_study_id>
    <nct_id>NCT04480411</nct_id>
  </id_info>
  <brief_title>Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients</brief_title>
  <official_title>Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the use of technology including remote vital sign
      monitoring in improving quality of patient care, decreasing hospital admissions and
      re-admissions, decreasing hospital length of stay and decreasing use of personal protective
      equipment.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital admission rate</measure>
    <time_frame>Up to 6 months (average expected time on study: 1 month)</time_frame>
    <description>Number of participants requiring initial hospital admission for COVID-19 during the study (outpatient groups only)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital re-admission rate</measure>
    <time_frame>Up to 6 months (average expected time on study: 1 month)</time_frame>
    <description>Number of participants requiring hospital re-admission for COVID-19 during the study (all groups)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>Up to 1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient provider experience survey score</measure>
    <time_frame>Once after completion of device use (up to 15 minutes to complete the survey)</time_frame>
    <description>Five questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 5 (higher scores = better experience).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Provider experience survey score</measure>
    <time_frame>Once after completion of device use (up to 15 minutes to complete the survey)</time_frame>
    <description>Four questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 4 (higher scores = better experience).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Use of personal protective improvement</measure>
    <time_frame>6 months</time_frame>
    <description>Level of personal protective improvement in an in-patient setting.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of in-patient encounters with COVID patients as a measure of provider exposure to high risk illness</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">165</enrollment>
  <condition>Diagnoses Disease</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Telemedicine Kit Group (Inpatients)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients that are admitted to the hospital with COVID 19.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemedicine Kit Group (Outpatients)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients that are persons under investigation for COVID 19 or diagnosed COVID 19 patients that are not ill enough to be hospitalized.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulse Oximetry Group (Inpatients)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients that are being discharged from the hospital with a diagnosis of COVID 19.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulse Oximetry Group (Outpatients)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients that are persons under investigation for COVID 19 or diagnosed COVID 19 patients that are not ill enough to be hospitalized</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Use of Doctorgram Patient Kit</intervention_name>
    <description>Participants will use the Doctorgram Patient Kit for remote monitoring. The kit includes remote use stethoscope, pulse oximeter, peak flow monitor, EKG monitor, blood pressure monitor.</description>
    <arm_group_label>Telemedicine Kit Group (Inpatients)</arm_group_label>
    <arm_group_label>Telemedicine Kit Group (Outpatients)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Use of Doctorgram Mobile Application</intervention_name>
    <description>Participants will use the Doctorgram mobile application to enable remote monitoring with Doctorgram Patient Kit.</description>
    <arm_group_label>Telemedicine Kit Group (Inpatients)</arm_group_label>
    <arm_group_label>Telemedicine Kit Group (Outpatients)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Use of Remote Pulse Oximeter</intervention_name>
    <description>Participants will use a remote pulse oximeter for monitoring oxygen saturation at home.</description>
    <arm_group_label>Pulse Oximetry Group (Inpatients)</arm_group_label>
    <arm_group_label>Pulse Oximetry Group (Outpatients)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalized patient with COVID 19 or outpatient under investigation for or diagnosed
             with COVID 19

          -  Patient has the ability to be trained in utilization of remote monitoring equipment

          -  Patient agrees for outpatient follow up with the Crown Clinic

          -  For the telemedicine kits-patient has a device that is compatible with the use of the
             Doctorgram application

          -  For the pulse oximetry study-Patient is stable for discharge from the hospital. For
             outpatients, patient does not require hospitalization.

        Exclusion Criteria:

          -  Patients under the age of 18

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ritu Parikh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julieta M Gabiola, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicholas Scoulios, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lisa Shieh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 17, 2020</study_first_submitted>
  <study_first_submitted_qc>July 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2020</study_first_posted>
  <last_update_submitted>September 4, 2020</last_update_submitted>
  <last_update_submitted_qc>September 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Telemedicine</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

